
浏览全部资源
扫码关注微信
1.重庆医科大学附属第一医院妇科,重庆 400016
2.重庆医科大学附属大学城医院体检中心,重庆 401331
龚赛楠,Email:1366293617@qq.com,研究方向:妇科肿瘤。
牟晓玲,Email:mxl@hospital.cqmu.edu.cn。
收稿:2023-01-29,
修回:2023-06-25,
录用:2023-06-30,
纸质出版:2023-10-28
移动端阅览
龚赛楠,孟雨,杜颖,等.探索子宫内膜间质肉瘤的临床预后因素[J].重庆医科大学学报,2023,48(10):1243-1247.
Gong Sainan,Meng Yu,Du Ying,et al.Exploring the clinical prognostic factors in endometrial stromal sarcoma[J].Journal of Chongqing Medical University,2023,48(10):1243-1247.
龚赛楠,孟雨,杜颖,等.探索子宫内膜间质肉瘤的临床预后因素[J].重庆医科大学学报,2023,48(10):1243-1247. DOI: 10.13406/j.cnki.cyxb.003342.
Gong Sainan,Meng Yu,Du Ying,et al.Exploring the clinical prognostic factors in endometrial stromal sarcoma[J].Journal of Chongqing Medical University,2023,48(10):1243-1247. DOI: 10.13406/j.cnki.cyxb.003342.
目的
2
回顾性分析子宫内膜间质肉瘤(endometrial stromal sarcoma,ESS)患者的临床转归结果,探讨影响其预后的因素。
方法
2
收集2009年6月至2020年3月重庆医科大学附属第一医院收治的82例ESS患者临床资料,统计患者年龄、体质指数(body mass index,BMI)、绝经状态、肿瘤大小、淋巴结切除、卵巢保留、组织学类型、分期、辅助治疗情况、CD10等,并对所有患者进行随访。采用统计学软件SPSS 25.0进行数据统计分析,Kaplan-Meier法和log-rank检验进行生存分析,通过Cox回归分析影响预后的因素。
结果
2
82例ESS患者纳入研究,随访时间为2~132个月,5年累计总生存率为71.8%。通过单因素分析发现,绝经状态、是否保留卵巢、组织学类型、分期、雌激素受体(estrogen receptor,ER)、孕激素受体(progesterone receptor,PR)和Ki-67指数与无进展生存期(progression-free survival,PFS)显著相关,绝经状态、肿瘤大小、组织学类型、分期、ER、PR和Ki-67指数与总生存期(overall survival,OS)显著相关。其中,组织学类型和是否保留卵巢是影响PFS的独立预后因素(
P
=0.010、0.013),组织学类型是影响OS的独立预后因素(
P
=0.033)。
结论
2
影响ESS预后的因素较多,组织学类型、是否保留卵巢是ESS的独立预后因素。
Objective
2
To perform a retrospective analysis of the clinical outcome of patients with endometrial stromal sarcoma(ESS) and to identify prognostic factors.
Methods
2
A total of 82 ESS patients were recruited from June 2009 to March 2020 in The First Affiliated Hospital of Chongqing Medical University. Their clinical data were collected and analyzed,including age,body mass index,menopausal status,tumor size,lymph node resection,ovarian preservation,histological type,stage,adjuvant therapy,and CD10. All patients were followed up. Statistical analysis was performed using SPSS 25.0,the Kaplan-Meier method and log-rank test were used for survival analysis,and
Cox
regression was used to analyze the prognostic factors.
Results
2
A total of 82 patients with ESS were enrolled in this study. The follow-up time was 2-132 months,and the 5-year cumulative overall survival rate was 71.8%. Univariate analysis showed that menopausal status,ovarian preservation,histological type,stage,and indices(ER,PR,and Ki-67) were significantly correlated with progression-free survival. While menopause status,tumor size,histological type,stage,and indices(ER,PR,and Ki-67) were significantly correlated with overall survival. Histological type and ovarian preservation were independent prognostic factors for progression-free survival(
P
=0.010,0.013),while histological type was an independent prognostic factor for overall survival(
P
=0.033).
Conclusion
2
There are many factors that affect the prognosis of ESS,and histological type and ovarian preservation are independent prognostic factors for ESS.
Zheng YW , Yin QH , Yang XS , et al . Fertility-sparing management of low-grade endometrial stromal sarcoma:analysis of an institutional series,a population-based analysis and review of the literature [J ] . Ann Transl Med , 2020 , 8 ( 21 ): 1358 .
Nath AG , Suchetha S , Rema PN , et al . Endometrial stromal sarcoma,an unusual recurrence:a case report [J ] . J Obstet Gynaecol India , 2021 , 71 ( 4 ): 448 - 451 .
Ali SI , Sayyed RH , Bakar MA , et al . A retrospective study of endometrial stromal sarcoma:an institutional review [J ] . J Pak Med Assoc , 2020 , 70 ( 5 ): 926 - 929 .
Gu YZ , Duan NY , Cheng HX , et al . Fertility-sparing surgeries without adjuvant therapy through term pregnancies in a patient with low-grade endometrial stromal sarcoma:a case report [J ] . World J Clin Cases , 2021 , 9 ( 4 ): 983 - 991 .
Gangireddy M , Chan Gomez J , Kanderi T , et al . Recurrence of endometrial stromal sarcoma,two decades post-treatment [J ] . Cureus , 2020 , 12 ( 7 ): e9249 .
Mbatani N , Olawaiye AB , Prat J . Uterine sarcomas [J ] . Int J Gynaecol Obstet , 2018 , 143 ( Suppl 2 ): 51 - 58 .
Reich O , Regauer S , Urdl W , et al . Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas [J ] . Br J Cancer , 2000 , 82 ( 5 ): 1030 - 1034 .
Haberal A , Kayikçioğlu F , Boran N , et al . Endometrial stromal sarcoma of the uterus:analysis of 25 patients [J ] . Eur J Obstet Gynecol Reprod Biol , 2003 , 109 ( 2 ): 209 - 213 .
Yu T , Kim HJ , Wu HG , et al . Outcome analysis in patients with uterine sarcoma [J ] . Radiat Oncol J , 2015 , 33 ( 1 ): 29 - 35 .
Kapp DS , Shin JY , Chan JK . Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas [J ] . Cancer , 2008 , 112 ( 4 ): 820 - 830 .
Wang M , Meng SH , Li B , et al . Survival outcomes of different treatment modalities in patients with low-grade endometrial stromal sarcoma [J ] . Chin Med J , 2019 , 132 ( 9 ): 1128 - 1132 .
Seagle BLL , Shilpi A , Buchanan S , et al . Low-grade and high-grade endometrial stromal sarcoma:a National Cancer Database study [J ] . Gynecol Oncol , 2017 , 146 ( 2 ): 254 - 262 .
Călin FD , Gheorghiu D , Ionescu CA , et al . Endometrial stromal sarcoma in a 27-year-old woman. Case report and literature review [J ] . Rom J Morphol Embryol , 2018 , 59 ( 3 ): 933 - 938 .
Macklon KT , Pedersen AT , Larsen EC , et al . Fertility counselling of younger women after cancer treatment [J ] . Adv Exp Med Biol , 2020 , 182 ( 53 ): V07200499 .
Yoon A , Park JY , Park JY , et al . Prognostic factors and outcomes in endometrial stromal sarcoma with the 2009 FIGO staging system:a multicenter review of 114 cases [J ] . Gynecol Oncol , 2014 , 132 ( 1 ): 70 - 75 .
Laurelli G , Falcone F , Scaffa C , et al . Fertility-sparing management of low-grade endometrial stromal sarcoma:analysis of an institutional series and review of the literature [J ] . Eur J Obstet Gynecol Reproductive Biol , 2015 , 195 : 61 - 66 .
周 莹 , 邓 姗 . 青年女性子宫内膜间质肉瘤:由一例特殊病例到21例病例的回顾性分析 [J ] . 生殖医学杂志 , 2018 , 27 ( 10 ): 986 - 993 .
Zhou Y , Deng S . Endometrial stromal sarcoma in young women:a case report and retrospective analysis of 21 cases [J ] . J Reproductive Med , 2018 , 27 ( 10 ): 986 - 993 .
Horng HC , Wen KC , Wang PH , et al . Uterine sarcoma Part Ⅱ——uterine endometrial stromal sarcoma:the TAG systematic review [J ] . Taiwan J Obstet Gynecol , 2016 , 55 ( 4 ): 472 - 479 .
Abu-Rustum NR , Yashar CM , Bradley K , et al . NCCN guidelines ® insights:uterine neoplasms,version 3.2021 [J ] . J Natl Compr Canc Netw , 2021 , 19 ( 8 ): 888 - 895 .
Meurer M , Floquet A , Ray-Coquard I , et al . Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma:a retrospective series of the French Sarcoma Group [J ] . Int J Gynecol Cancer , 2019 , 29 : 691 - 698 .
Cabrera S , Bebia V , Acosta U , et al . Survival outcomes and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma [J ] . Clin Transl Oncol , 2021 , 23 ( 6 ): 1210 - 1219 .
0
浏览量
6
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621